Copyright Reports & Markets. All rights reserved.

Covid-19 Impact on Hyoscine Market, Global Research Reports 2020-2021

Buy now
  • 1.1 Research Scope
  • 1.2 Market Segmentation
  • 1.3 Research Objectives
  • 1.4 Research Methodology
    • 1.4.1 Research Process
    • 1.4.2 Data Triangulation
    • 1.4.3 Research Approach
    • 1.4.4 Base Year
  • 1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
    • 1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
    • 1.5.2 Covid-19 Impact: Commodity Prices Indices
    • 1.5.3 Covid-19 Impact: Global Major Government Policy
  • 1.6 The Covid-19 Impact on Hyoscine Industry
  • 1.7 COVID-19 Impact: Hyoscine Market Trends
  • 2 Global Hyoscine Quarterly Market Size Analysis

    • 2.1 Hyoscine Business Impact Assessment - COVID-19
      • 2.1.1 Global Hyoscine Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
      • 2.1.2 Global Hyoscine Price, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
    • 2.2 Global Hyoscine Quarterly Market Size 2020-2021
    • 2.3 COVID-19-Driven Market Dynamics and Factor Analysis
      • 2.3.1 Drivers
      • 2.3.2 Restraints
      • 2.3.3 Opportunities
      • 2.3.4 Challenges

    3 Quarterly Competitive Assessment, 2020

    • 3.1 Global Hyoscine Quarterly Market Size by Manufacturers, 2019 VS 2020
    • 3.2 Global Hyoscine Factory Price by Manufacturers
    • 3.3 Location of Key Manufacturers Hyoscine Manufacturing Factories and Area Served
    • 3.4 Date of Key Manufacturers Enter into Hyoscine Market
    • 3.5 Key Manufacturers Hyoscine Product Offered
    • 3.6 Mergers & Acquisitions, Expansion Plans

    4 Impact of Covid-19 on Hyoscine Segments, By Type

    • 4.1 Introduction
      • 1.4.1 Hyoscine Butylbromide
      • 1.4.2 Hyoscine Hydrobromide
    • 4.2 By Type, Global Hyoscine Market Size, 2019-2021
      • 4.2.1 By Type, Global Hyoscine Market Size by Type, 2020-2021
      • 4.2.2 By Type, Global Hyoscine Price, 2020-2021

    5 Impact of Covid-19 on Hyoscine Segments, By Application

    • 5.1 Overview
      • 5.5.1 Oral
      • 5.5.2 Injections
      • 5.5.3 Patches
    • 5.2 By Application, Global Hyoscine Market Size, 2019-2021
      • 5.2.1 By Application, Global Hyoscine Market Size by Application, 2019-2021
      • 5.2.2 By Application, Global Hyoscine Price, 2020-2021

    6 Geographic Analysis

    • 6.1 Introduction
    • 6.2 North America
      • 6.2.1 Macroeconomic Indicators of US
      • 6.2.2 US
      • 6.2.3 Canada
    • 6.3 Europe
      • 6.3.1 Macroeconomic Indicators of Europe
      • 6.3.2 Germany
      • 6.3.3 France
      • 6.3.4 UK
      • 6.3.5 Italy
    • 6.4 Asia-Pacific
      • 6.4.1 Macroeconomic Indicators of Asia-Pacific
      • 6.4.2 China
      • 6.4.3 Japan
      • 6.4.4 South Korea
      • 6.4.5 India
      • 6.4.6 ASEAN
    • 6.5 Rest of World
      • 6.5.1 Latin America
      • 6.5.2 Middle East and Africa

    7 Company Profiles

    • 7.1 Alchem International Ltd.
      • 7.1.1 Alchem International Ltd. Business Overview
      • 7.1.2 Alchem International Ltd. Hyoscine Quarterly Production and Revenue, 2020
      • 7.1.3 Alchem International Ltd. Hyoscine Product Introduction
      • 7.1.4 Alchem International Ltd. Response to COVID-19 and Related Developments
    • 7.2 Alkaloids Corporation
      • 7.2.1 Alkaloids Corporation Business Overview
      • 7.2.2 Alkaloids Corporation Hyoscine Quarterly Production and Revenue, 2020
      • 7.2.3 Alkaloids Corporation Hyoscine Product Introduction
      • 7.2.4 Alkaloids Corporation Response to COVID-19 and Related Developments
    • 7.3 Baxter International Inc.
      • 7.3.1 Baxter International Inc. Business Overview
      • 7.3.2 Baxter International Inc. Hyoscine Quarterly Production and Revenue, 2020
      • 7.3.3 Baxter International Inc. Hyoscine Product Introduction
      • 7.3.4 Baxter International Inc. Response to COVID-19 and Related Developments
    • 7.4 Caleb Pharmaceuticals, Inc.
      • 7.4.1 Caleb Pharmaceuticals, Inc. Business Overview
      • 7.4.2 Caleb Pharmaceuticals, Inc. Hyoscine Quarterly Production and Revenue, 2020
      • 7.4.3 Caleb Pharmaceuticals, Inc. Hyoscine Product Introduction
      • 7.4.4 Caleb Pharmaceuticals, Inc. Response to COVID-19 and Related Developments
    • 7.5 Centroflora Cms S. R.L.
      • 7.5.1 Centroflora Cms S. R.L. Business Overview
      • 7.5.2 Centroflora Cms S. R.L. Hyoscine Quarterly Production and Revenue, 2020
      • 7.5.3 Centroflora Cms S. R.L. Hyoscine Product Introduction
      • 7.5.4 Centroflora Cms S. R.L. Response to COVID-19 and Related Developments
    • 7.6 GlaxoSmithKline Plc
      • 7.6.1 GlaxoSmithKline Plc Business Overview
      • 7.6.2 GlaxoSmithKline Plc Hyoscine Quarterly Production and Revenue, 2020
      • 7.6.3 GlaxoSmithKline Plc Hyoscine Product Introduction
      • 7.6.4 GlaxoSmithKline Plc Response to COVID-19 and Related Developments
    • 7.7 Guangzhou Hanfang Pharmaceutical Co., Ltd.
      • 7.7.1 Guangzhou Hanfang Pharmaceutical Co., Ltd. Business Overview
      • 7.7.2 Guangzhou Hanfang Pharmaceutical Co., Ltd. Hyoscine Quarterly Production and Revenue, 2020
      • 7.7.3 Guangzhou Hanfang Pharmaceutical Co., Ltd. Hyoscine Product Introduction
      • 7.7.4 Guangzhou Hanfang Pharmaceutical Co., Ltd. Response to COVID-19 and Related Developments
    • 7.8 Myungmoon Pharma Co., Ltd.
      • 7.8.1 Myungmoon Pharma Co., Ltd. Business Overview
      • 7.8.2 Myungmoon Pharma Co., Ltd. Hyoscine Quarterly Production and Revenue, 2020
      • 7.8.3 Myungmoon Pharma Co., Ltd. Hyoscine Product Introduction
      • 7.8.4 Myungmoon Pharma Co., Ltd. Response to COVID-19 and Related Developments
    • 7.9 Novartis International AG
      • 7.9.1 Novartis International AG Business Overview
      • 7.9.2 Novartis International AG Hyoscine Quarterly Production and Revenue, 2020
      • 7.9.3 Novartis International AG Hyoscine Product Introduction
      • 7.9.4 Novartis International AG Response to COVID-19 and Related Developments
    • 7.10 Perrigo Company Plc
      • 7.10.1 Perrigo Company Plc Business Overview
      • 7.10.2 Perrigo Company Plc Hyoscine Quarterly Production and Revenue, 2020
      • 7.10.3 Perrigo Company Plc Hyoscine Product Introduction
      • 7.10.4 Perrigo Company Plc Response to COVID-19 and Related Developments

    8 Supply Chain and Sales Channels Analysis

    • 8.1 Hyoscine Supply Chain Analysis
      • 8.1.1 Hyoscine Supply Chain Analysis
      • 8.1.2 Covid-19 Impact on Hyoscine Supply Chain
    • 8.2 Distribution Channels Analysis
      • 8.2.1 Hyoscine Distribution Channels
      • 8.2.2 Covid-19 Impact on Hyoscine Distribution Channels
      • 8.2.3 Hyoscine Distributors
    • 8.3 Hyoscine Customers

    9 Key Findings

      10 Appendix

      • 10.1 About Us

      This report covers market size and forecasts of Hyoscine, including the following market information:
      Global Hyoscine Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Hyoscine Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Hyoscine Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million) & (K Units)
      Global Hyoscine Market Size by Company, 2019- 2020 (quarterly data), (US$ Million) & (K Units)

      Key market players
      Major competitors identified in this market include Alchem International Ltd., Alkaloids Corporation, Baxter International Inc., Caleb Pharmaceuticals, Inc., Centroflora Cms S. R.L., GlaxoSmithKline Plc, Guangzhou Hanfang Pharmaceutical Co., Ltd., Myungmoon Pharma Co., Ltd., Novartis International AG, Perrigo Company Plc, etc.

      Based on the Region:
      Asia-Pacific (China, Japan, South Korea, India and ASEAN)
      North America (US and Canada)
      Europe (Germany, France, UK and Italy)
      Rest of World (Latin America, Middle East & Africa)

      Based on the Type:
      Hyoscine Butylbromide
      Hyoscine Hydrobromide

      Based on the Application:
      Oral
      Injections
      Patches

      Buy now